News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bio NC
Salix Pharmaceuticals, Ltd. to Present at Roth Capital Partners Conference
February 13, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the Roth Capital Partners 20th Annual OC Growth Conference in Laguna Niguel, CA on Wednesday, February 20 at 2:00 p.m. ET.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Cancer
ASCO: A battle of bispecifics, Eli Lilly’s big win and more
June 1, 2026
·
4 min read
·
Brianna Abbott
Pancreatic cancer
ASCO: Biopharma has pancreatic cancer ‘surrounded’ as Immuneering’s drug adds 9 quality months
June 1, 2026
·
5 min read
·
Heather McKenzie
Regulatory
Pazdur declines to announce candidacy for vacated FDA commissioner role
May 20, 2026
·
4 min read
·
Heather McKenzie
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
May 5, 2026
·
4 min read
·
Heather McKenzie